Headlines

Postmastectomy Breast Reconstruction Safe in Older Women With Breast Cancer

Postmastectomy Breast Reconstruction Safe in Older Women With Breast Cancer

Few women aged 70 and older with breast cancer undergo postmastectomy breast reconstruction due to potential complications; however, these patients are not less likely to have good outcomes.

CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?

CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?

Researchers sought to determine how subjective measures of CIPN correlated with objective measures of CIPN.

Risk of Breast Cancer Higher for African American Female Veterans

Risk of Breast Cancer Higher for African American Female Veterans

Pilot study sought to determine risk of breast cancer among African American women veterans.

Patients, Physicians Do Not Recognize Fatigue the Same

Patients, Physicians Do Not Recognize Fatigue the Same

A worldwide survey reveals that despite similar perceptions on symptom burden of ITP, patients and physicians do not agree on the effect of fatigue on quality of life.

PFS, OS Improved With Sequential Rituximab/Bendamustine, Rituximab/Cytarabine in Untreated Mantle Cell Lymphoma

PFS, OS Improved With Sequential Rituximab/Bendamustine, Rituximab/Cytarabine in Untreated Mantle Cell Lymphoma

Two simultaneous studies demonstrate improved progression-free survival and overall survival in patients with uMCL who receive induction therapy with RB/RC followed by ASCT.

Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value

Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value

Stringent CR criteria may not predict clinical outcomes for patients with multiple myeloma.

Rituximab Biosimilar CT-P10 Equivalent as Monotherapy for Follicular Lymphoma

Rituximab Biosimilar CT-P10 Equivalent as Monotherapy for Follicular Lymphoma

US FDA recently approved rituximab biosimilar as monotherapy and in combination with chemotherapy.

A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL

A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL

Checkpoint-based therapies may sensitize patients to subsequent therapies.

Curative Option Identified for Squamous Cell Carcinoma of the Anal Canal With Distant Metastasis

Curative Option Identified for Squamous Cell Carcinoma of the Anal Canal With Distant Metastasis

A retrospective review identified a subset of patients with squamous cell carcinoma of the anal canal with distant metastases who respond to extended-field chemoradiation.

Perspectives on Use of Sensored Medication Devices From Patients With Multiple Myeloma

Perspectives on Use of Sensored Medication Devices From Patients With Multiple Myeloma

Researchers conducted a study to gauge the potential acceptance of sensored medication devices among patients with multiple myeloma.

Conference Coverage

Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value

Stringent CR criteria may not predict clinical outcomes for patients with multiple myeloma.

A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL

Checkpoint-based therapies may sensitize patients to subsequent therapies.

Prior Bortezomib Lowers Incidence of Lenalidomide-Induced Skin Toxicity in Multiple Myeloma

A study presented at ESMO 2018 demonstrated that incidence of skin toxicity in patients with multiple myeloma undergoing lenalidomide therapy was lower in those who received prior bortezomib.

Nonadherence to Tamoxifen Higher Than Reported Among Premenopausal Patients With Breast Cancer

Assessment of a subgroup of a cohort study revealed that many patients undergoing tamoxifen therapy for early-stage breast cancer do not adhere to their prescribed treatment, even though they claim adherence on patient surveys.

Chemotherapy Side Effects in Women vs Men: Broader Range, More Severe

An analysis of pooled data from 4 randomized controlled clinical trials revealed that male and female patients experience different chemotherapy side effects and at different severities, according to a poster presented at ESMO 2018 Congress.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs